Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments ... which was recently approved in the United States as a treatment for some ...

Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

MoneyShow presents top investment ideas for 2024 from leading advisors. Part 10 includes Advanced Micro Devices, Novo Nordisk ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

The Trump administration has promised that addressing childhood obesity will be a key part of its “Make America Healthy Again ...

The Obesity Action Coalition (OAC) is proud to celebrate its 20th Anniversary, marking two decades of empowering individuals affected by the disease of obesity through advocacy, awareness, education ...

Is obesity a risk factor or a disease? This debate shapes treatments, policies, and eating disorder care. Explore its impact ...

Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with ...

Jan. 27, 2025 — A study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) surgery significantly lowered their future ... Signposting Children to ...

As employers face growing challenges in addressing obesity and its related conditions, the Midwest Health Purchasers ...

From 2013-2014 to August 2021-August 2023, there were small increases in the percentage of children and adolescents with obesity, as well as in adults with severe obesity (but not obesity). There were ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.